| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 267.51B | 284.31B | 316.62B | 381.31B | 261.50B |
| Gross Profit | 44.59B | 45.94B | 47.21B | 78.78B | 35.85B |
| EBITDA | 53.00B | 61.65B | 60.36B | 92.55B | 56.51B |
| Net Income | 17.88B | 16.09B | 19.36B | 42.31B | 20.10B |
Balance Sheet | |||||
| Total Assets | 370.35B | 387.61B | 406.27B | 443.02B | 404.38B |
| Cash, Cash Equivalents and Short-Term Investments | 30.22B | 39.11B | 38.77B | 40.25B | 36.97B |
| Total Debt | 104.58B | 77.14B | 81.64B | 83.80B | 89.09B |
| Total Liabilities | 195.03B | 207.44B | 217.91B | 250.43B | 229.05B |
| Stockholders Equity | 174.39B | 178.31B | 186.61B | 190.47B | 171.97B |
Cash Flow | |||||
| Free Cash Flow | 21.82B | 35.08B | 31.20B | 45.81B | 26.11B |
| Operating Cash Flow | 40.81B | 54.68B | 54.19B | 68.41B | 45.10B |
| Investing Cash Flow | -18.83B | -15.15B | -17.73B | -22.45B | -4.76B |
| Financing Cash Flow | -31.76B | -38.43B | -38.23B | -41.95B | -34.66B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | $421.33B | 24.67 | 7.33% | 4.54% | -3.44% | -22.05% | |
73 Outperform | $712.47B | 18.07 | 11.04% | 3.35% | -4.17% | -14.15% | |
71 Outperform | $260.69B | 12.10 | 10.06% | 3.92% | -6.96% | 0.03% | |
66 Neutral | $104.95B | 12.11 | 3.33% | 7.43% | 1.53% | -35.81% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% | |
60 Neutral | $119.63B | 1,640.39 | 0.10% | 5.62% | -4.11% | -37.59% |